Clinical Trial Update: Intravenous Immunoglobulin (IVIG) in Lung Transplantation [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating intravenous immunoglobulin (IVIG) in patients undergoing lung transplantation has been completed, with results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogammaglobulinemia
• Lung Transplantation

Drugs mentioned

• Intravenous Immunoglobulin (IVIG)

Snippet

Sponsor: Columbia University | Conditions: Hypogammaglobulinemia, Lung Transplantation | Phase 2 | Status: COMPLETED | Results posted: 2019-03-05